Company Filing History:
2 out of 845 
1 out of 2 Years Active: 2006-2009
Title: Vince Laterza: Innovator in Monoclonal Antibody Production
Introduction
Vince Laterza is a notable inventor based in Decatur, GA (US). He has made significant contributions to the field of biotechnology, particularly in the rapid production of monoclonal antibodies. With a total of 2 patents, Laterza's work has advanced the methods used in antibody production, which is crucial for various medical applications.
Latest Patents
Laterza's latest patents include innovative technologies that focus on genetically altered hybridomas, myelomas, and B cells. The first patent relates to genetically altered hybridomas, myelomas, and B cells that facilitate the rapid production of monoclonal antibodies. This invention provides populations of hybridomas and B cells that can be utilized to create a monoclonal antibody of interest. The second patent outlines a method for the rapid production of hybridomas expressing monoclonal antibodies on the cell surface, further enhancing the efficiency of antibody production.
Career Highlights
Throughout his career, Vince Laterza has worked with esteemed organizations such as the University of Georgia Research Foundation, Inc. and Abeome Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
One of Laterza's notable coworkers is Richard B. Meagher. Their collaboration has likely fostered innovative ideas and advancements in the field of monoclonal antibody production.
Conclusion
Vince Laterza's contributions to biotechnology, particularly in the area of monoclonal antibody production, have made a significant impact on the industry. His patents and collaborations reflect his dedication to advancing scientific research and innovation.